Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Alkem Laboratories Limited (NSE: ALKEM), ISIN INE540L01014 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ALKEM last traded at ₹5373.55 (+1.45%), with a 52-week range of ₹4811.00 to ₹5933.50 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 49.70%, FIIs 10.32%, DIIs 22.83%, mutual funds 17.79%.
EquiSense Score (ECS): 66/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.